Nicotinamide mononucleotide for neuroenhancement and neuroprotection in glaucoma – a randomized controlled trial

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Nicotinamide mononucleotide for neuroenhancement and neuroprotection in glaucoma – a randomized controlled trial
Principal Investigator
Professor Leung, Kai Shun   (Principal Investigator (PI))
Co-Investigator(s)
Dr Chan Poemen Pui-man   (Co-Investigator)
Duration
36
Start Date
2024-11-01
Amount
1500000
Conference Title
Nicotinamide mononucleotide for neuroenhancement and neuroprotection in glaucoma – a randomized controlled trial
Keywords
glaucoma, nicotinamide, neuroenhacement, neuroprotection, visual field sensitivity
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
11221896
Grant Type
Health and Medical Research Fund 2022
Funding Year
2023
Status
On-going
Objectives
 To investigate the neuroenhancement and neuroprotective effects of nicotinamide mononucleotide (NMN) in patients with primary open-angle glaucoma (POAG).